carbapenems has been researched along with Infective Endocarditis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Courtois, R; Danneels, P; Dubée, V; Eveillard, M; Kempf, M; Mahieu, R; Quinqueneau, C; Rihet, C; Vannier, C | 1 |
| Hollenberg, SM; Khan, ZA | 1 |
| Ohnishi, K | 1 |
2 review(s) available for carbapenems and Infective Endocarditis
| Article | Year |
|---|---|
Valvular Heart Disease in Adults: Infective Endocarditis.
Topics: Anti-Bacterial Agents; Blood Culture; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Echocardiography; Endocarditis; Endocarditis, Bacterial; Gentamicins; Heart Valve Prosthesis; Humans; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 2017 |
[Campylobacter infection].
Topics: Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Endocarditis; Gastroenteritis; Guillain-Barre Syndrome; Humans; Macrolides; Meningitis, Bacterial; Miller Fisher Syndrome; Prognosis; Sepsis; Zoonoses | 2003 |
1 other study(ies) available for carbapenems and Infective Endocarditis
| Article | Year |
|---|---|
Cefoxitin-based combination for ESBL-producing Enterobacteriaceae endocarditis.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Endocarditis; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 2022 |